Barr Moves To Get Plan B To The Market
After meeting with officials from the U.S. Food and Drug Administration Tuesday, Barr Pharmaceuticals Inc. plans to amend its request to sell its morning-after contraceptive pill without prescription within the next...To view the full article, register now.
Already a subscriber? Click here to view full article